Arbutus Biopharma Corporation logo

Arbutus Biopharma Corporation (ABUS)

Market Closed
8 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
4. 52
+0.1
+2.26%
After Hours
$
4. 52
0 0%
847.53M Market Cap
- P/E Ratio
0% Div Yield
756,097 Volume
-0.45 Eps
$ 4.42
Previous Close
Day Range
4.38 4.55
Year Range
2.71 5.1
Want to track ABUS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 80 days
Name Time Cons. EPS Eps
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
26 Feb 2026 (In 2 months)
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
13 Nov 2025
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
5 Nov 2025
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
4 Nov 2025
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
31 Jul 2025
-
0.01
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
30 Apr 2025
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
26 Feb 2025
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
5 Nov 2024
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
1 Aug 2024
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
2 May 2024
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
29 Feb 2024
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
7 Nov 2023
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
3 Nov 2016
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
4 Aug 2016
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
4 May 2016
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
9 Mar 2016
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
5 Nov 2015
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
7 Aug 2015
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
6 May 2015
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
12 Mar 2015
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
6 Nov 2014
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
13 Aug 2014
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
14 May 2014
0.23
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
6 Mar 2014
0.05
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
13 Nov 2013
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
12 Aug 2013
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
14 May 2013
-
-
Arbutus Biopharma Corporation logo
ABUS Arbutus Biopharma Corporation
27 Mar 2013
-
2.7

ABUS Earnings Reports FAQ

What is the earnings per share (EPS) for ABUS?

The current EPS is -0.45.

What is the company's earnings growth rate?

Over the past 12 years, the earnings growth rate has been approximately -35.57%, reflecting the ABUS's performance and NASDAQ (NGS) market conditions.

When is the next earnings release date?

The next earnings release is expected to be on 2026-02-26, based on the ABUS's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Arbutus Biopharma Corporation are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for ABUS at this time, as Arbutus Biopharma Corporation has no recent EPS data to calculate it.